compound 21
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 3, 2022 (NCT05576155)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
AGTR2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06157580 | Early Phase 1 (Phase 1) | Dec 1, 2023 | University of Iowa |
| NCT05937841 | Early Phase 1 (Phase 1) | Jun 28, 2023 | University of Iowa |
| NCT05576155 | Early Phase 1 (Phase 1) | Oct 3, 2022 | University of Iowa |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Iowa | Academic/Hospital | 3 | 3 | 1 | 2022 |
1 organizations
Page 1 / 1